What is Visit?
Visit is an AI-driven platform based in New Delhi, India, dedicated to empowering individuals in managing their health. The platform offers a holistic approach, assisting users with symptom diagnosis, lifestyle adjustments, chronic condition management, and facilitating consultations with specialists. By leveraging artificial intelligence, Visit aims to provide accessible and personalized healthcare solutions, bridging the gap between patients and medical expertise.
How much funding has Visit raised?
Visit has raised a total of $31.1M across 2 funding rounds:
Angel/Seed
$1.4M
Stock Offering
$29.7M
Angel/Seed (2021): $1.4M with participation from Kunal Bahl, Rohit Bansal, MapmyIndia, and Murali Krishna
Stock Issuance/Offering (2024): $29.7M led by Docprime
Key Investors in Visit
MapmyIndia
MapmyIndia, officially C.E. Info Systems Limited, is a leading Indian provider of digital maps and geospatial software. Their investment in Visit suggests a strategic interest in integrating location-based services or data analytics into the healthcare platform.
Docprime
Docprime is a comprehensive healthcare platform offering services like online consultations and claims management. Their participation in Visit's funding round indicates a potential synergy in expanding digital healthcare accessibility and service offerings.
What's next for Visit?
The recent major strategic investment in Visit signals a pivotal growth phase for the company. This substantial capital infusion is expected to fuel expansion initiatives, enhance technological capabilities, and broaden the platform's reach. With a focus on scaling its AI-driven diagnostic and management tools, Visit is poised to further solidify its presence in the digital health sector, potentially exploring new service offerings and strategic partnerships to optimize patient care and operational efficiency.
See full Visit company page
